Cargando…
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
BACKGROUND/AIMS: Many patients with Crohn’s disease (CD) undergo intestinal resection during the disease course. Despite surgery, postoperative recurrence (POR) commonly occurs. Although postoperative use of tumor necrosis factor α (TNF-α) inhibitors is known to be effective in preventing POR, few s...
Autores principales: | Yu, Jongwook, Hyun, Hye Kyung, Park, Jihye, Kang, Eun Ae, Park, Soo Jung, Park, Jae Jun, Kim, Tae Il, Kim, Won Ho, Cheon, Jae Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099390/ https://www.ncbi.nlm.nih.gov/pubmed/34420935 http://dx.doi.org/10.5009/gnl210062 |
Ejemplares similares
-
Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
por: Hyun, Hye Kyung, et al.
Publicado: (2022) -
Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
por: Hyun, Hye Kyung, et al.
Publicado: (2022) -
Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease
por: Kim, Sung Bae, et al.
Publicado: (2020) -
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
por: Yu, Jongwook, et al.
Publicado: (2021) -
Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)